Studies at the Microbicide Trials Network are designed specifically to support the potential licensure and regulatory approval of HIV prevention products for populations most vulnerable to HIV.
The Microbicide Trials Network is a U.S. National Institutes of Health-funded worldwide collaborative clinical trials network focused on preventing the sexual transmission of HIV.
Researchers at the MTN include international investigators and community and industry partners who work together to evaluate promising microbicide products.
More than 25 clinical research sites on four continents have partnered with the Microbicide Trials Network in the conduct of its clinical trials.
The MTN partners with key civil society groups and other stakeholders to solicit their views on proposed studies and to discuss issues related to study implementation.
Final results of HOPE presented at IAS 2019.
MTN-035 (DESIRE) is launched.
MTN held a MTN-042 and MTN-043 stakeholder consultation in Kampala, Uganda.
Results of open-label study of a vaginal ring for HIV prevention suggest women are interested in and willing to use it
What do people who practice anal sex desire for preventing HIV?
Microbicide Trials Network